
Reset all filters
01 1MERCK KGAA
02 2Merck (Switzerland) Ag
03 1Merck Europe B.V.
04 1Merck Europe Bv
05 1Merck Germany
Reset all filters
01 5Cetuximab
02 1Ifl Protocol
Reset all filters
01 1Cetuximab 100Mg 20Ml 1 Units Parenteral Use
02 4Infusion Solution
03 1Solution For Perfusion
Reset all filters
01 1Italy
02 1Spain
03 2Sweden
04 2Switzerland
Reset all filters
01 6Erbitux
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Erbitux
Dosage Form : Infusion Solution
Dosage Strength : 5mg/ml
Packaging :
Approval Date : 20/02/2007
Application Number : 20060320000016
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Erbitux
Dosage Form : Infusion Solution
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 29/06/2004
Application Number : 20040607002261
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Erbitux
Dosage Form : Solution For Perfusion
Dosage Strength : 5MG
Packaging :
Approval Date : 2007-05-17
Application Number : 04281003
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Erbitux
Dosage Form : Infusion Solution
Dosage Strength : 100mg/20ml
Packaging :
Approval Date : 01/12/2003
Application Number : 56072
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Erbitux
Dosage Form : Infusion Solution
Dosage Strength : 500mg/100ml
Packaging :
Approval Date : 01/12/2003
Application Number : 56072
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Erbitux
Dosage Form : Cetuximab 100Mg 20Ml 1 Units Parenteral Use
Dosage Strength : 1 vial Chk 20 ml 5 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy